Literature DB >> 23956025

Breast implants and anaplastic large-cell lymphoma: a danish population-based cohort study.

Maja Ølholm Vase1, Søren Friis, Andrea Bautz, Knud Bendix, Henrik Toft Sørensen, Francesco d'Amore.   

Abstract

BACKGROUND: A potential link between breast implants and anaplastic large-cell lymphoma (ALCL) has been suggested.
METHODS: We examined lymphoma occurrence in a nationwide cohort of 19,885 Danish women who underwent breast implant surgery during 1973-2010. Standardized incidence ratios (SIR), with 95% confidence intervals (CI), for ALCL and lymphoma overall associated with breast implantation were calculated.
RESULTS: During 179,246 person-years of follow-up, we observed 31 cases of lymphoma among cohort members. No cases of ALCL were identified. SIRs for ALCL and lymphoma overall were zero (95% CI, 0-10.3) and 1.20 (95% CI, 0.82-1.70), respectively.
CONCLUSIONS: In our nationwide cohort study, we did not find an increased risk of lymphoma in general, or ALCL in particular, among Danish women who underwent breast implantation. However, our evaluation of ALCL risk was limited by the rarity of the disease. IMPACT: Our results do not support an association between breast implants and ALCL and are consistent with other studies on cancer risk and breast implants. ©2013 AACR.

Entities:  

Mesh：

Year:  2013        PMID： 23956025     DOI： 10.1158/1055-9965.EPI-13-0633

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


  8 in total

1.  Identification of autoantibodies to ECH1 and HNRNPA2B1 as potential biomarkers in the early detection of lung cancer.

Authors:  Liping Dai; Jitian Li; Jun-Chieh J Tsay; Ting-An Yie; John S Munger; Harvey Pass; William N Rom; Eng M Tan; Jian-Ying Zhang
Journal:  Oncoimmunology       Date:  2017-03-31       Impact factor: 8.110

2.  Comprehensive Evaluation of the Current Knowledge on Breast Implant Associated-Anaplastic Large Cell Lymphoma.

Authors:  Hyokyung Yoo; Ji-Ung Park; Hak Chang
Journal:  Arch Plast Surg       Date:  2022-04-06

3.  Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.

Authors:  C Laurent; A Delas; P Gaulard; C Haioun; A Moreau; L Xerri; A Traverse-Glehen; T Rousset; I Quintin-Roue; T Petrella; J F Emile; N Amara; P Rochaix; M P Chenard-Neu; A M Tasei; E Menet; H Chomarat; V Costes; L Andrac-Meyer; J F Michiels; C Chassagne-Clement; L de Leval; P Brousset; G Delsol; L Lamant
Journal:  Ann Oncol       Date:  2015-11-23       Impact factor: 32.976

4.  Breast implants and anaplastic large cell lymphomas among females in the California Teachers Study cohort.

Authors:  Sophia S Wang; Dennis Deapen; Jenna Voutsinas; James V Lacey; Yani Lu; Huiyan Ma; Christina A Clarke; Dennis Weisenburger; Stephen J Forman; Leslie Bernstein
Journal:  Br J Haematol       Date:  2015-10-12       Impact factor: 6.998

5.  How I treat breast implant-associated anaplastic large cell lymphoma.

Authors:  Neha Mehta-Shah; Mark W Clemens; Steven M Horwitz
Journal:  Blood       Date:  2018-09-12       Impact factor: 22.113

Review 6.  Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management.

Authors:  Daniel Fleming; Jason Stone; Patrick Tansley
Journal:  Aesthetic Plast Surg       Date:  2018-02-14       Impact factor: 2.326

7.  Incidence of benign and malignant peri-implant fluid collections and masses on magnetic resonance imaging in women with silicone implants.

Authors:  Elizabeth J Sutton; Brittany Z Dashevsky; Elizabeth J Watson; Neelam Tyagi; Blanca Bernard-Davila; Danny Martinez; Ahmet Dogan; Steven M Horwitz; Peter G Cordeiro; Elizabeth A Morris
Journal:  Cancer Med       Date:  2019-09-30       Impact factor: 4.452

Review 8.  Current Progress in Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Authors:  Yichen Wang; Qi Zhang; Yufang Tan; Wenchang Lv; Chongru Zhao; Mingchen Xiong; Kai Hou; Min Wu; Yuping Ren; Ning Zeng; Yiping Wu
Journal:  Front Oncol       Date:  2022-01-06       Impact factor: 6.244
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.